Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy
Part of paid clinical trials in Knoxville, Tennessee.
- Sponsor
- Covenant Health Cancer Center
- Study ID
- NCT06183268
- Status
- Recruiting
Conditions
- Head and Neck Cancer
- Head and Neck Carcinoma
- Head and Neck Squamous Cell Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Spot Delete — RADIATIONThe treatments plans will utilize the scripted spot delete method to remove spots from the skin rind. To ensure all relevant skin spots are removed, the "SkinSpots" structure will be a 0.5 cm rind extending inward from the skin contour within 5 cm of the CTV. Spots will be removed from this structure and optimization will continue. Optimization objectives will be utilized to spare the skin rind structure during treatment planning, in addition to deleting spots.
Study Details
This purpose of this study is to examine skin reactions (called radiation dermatitis) that occur during pencil beam scanning (PBS) proton therapy. The researchers will test a unique technique called "Spot Delete" to see if it can reduce skin reactions for head \& neck patients treated with PBS. The investigators will also use a special computer model to study how the energy of the proton beam (linear energy transfer) is related to these skin reactions. The study involves creating a treatment plan based on a CT scan, which helps guide the proton beam in the body.
Key Dates
- Start date
- Dec 13, 2023
- Status verified
- Apr 2025
- Primary completion
- Jan 2, 2028
- Completion
- Jan 2, 2030
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Primary Outcome Measure
"Spot Delete: Technique in Proton Therapy Reduces Radiation Dermatitis in Head and Neck Cancer Patients. [ Time Frame: Weekly Assessments over 10 weeks, 1 month and 6 months post treatment ]
Central Contacts
- Samantha Hedrick, PhD, DABR865-862-1600
- Catherine Duke-Taylor, BS865-862-1600
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Thompson Proton Center | Knoxville | Tennessee | 37909 | Ryan Grover, MD (SUB_INVESTIGATOR) Brion Shin, MD (SUB_INVESTIGATOR) Allen Meek, MD (SUB_INVESTIGATOR) Chester Ramsey, PhD (SUB_INVESTIGATOR) Samantha Hedrick, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Knoxville, TN
Related Studies
- Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy ParticipantsRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryPHASE2 · Recruiting · ECOG-ACRIN Cancer Research Group · Birmingham, Alabama
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsPHASE1 · Recruiting · Bicara Therapeutics · La Jolla, California